ARWR : Arrowhead Pharmaceuticals stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)

The 6 Wall Street analysts offering Arrowhead Pharmaceuticals stock forecast in the last 6 months have average price target of $86.83 with a high forecast of $106.0 and a low forecast of $34.0. The average Arrowhead Pharmaceuticals stock forecast represents a 22.31% increase from the last price of $70.99. From AI system, total return is 2053.81% from 1638 forecasts. For Arrowhead Pharmaceuticals stock forecast 2021, 8 predictions are offered for each month of 2021 with average Arrowhead Pharmaceuticals stock forecast of $50.25, a high forecast of $63.47, and a low forecast of $45.89. The average Arrowhead Pharmaceuticals stock forecast 2021 represents a -29.21% decrease from the last price of $70.99. For Arrowhead Pharmaceuticals stock forecast 2022, 12 predictions are offered for each month of 2022 with average Arrowhead Pharmaceuticals stock forecast of $39.56, a high forecast of $46.2, and a low forecast of $32.09. The average Arrowhead Pharmaceuticals stock forecast 2022 represents a -44.27% decrease from the last price of $70.99. For Arrowhead Pharmaceuticals stock forecast 2025, 12 predictions are offered for each month of 2025 with average Arrowhead Pharmaceuticals stock forecast of $7.82, a high forecast of $8.43, and a low forecast of $7.19. The average Arrowhead Pharmaceuticals stock forecast 2025 represents a -88.99% decrease from the last price of $70.99. For Arrowhead Pharmaceuticals stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Arrowhead Pharmaceuticals stock forecast of $5.72, a high forecast of $6.89, and a low forecast of $4.8. The average Arrowhead Pharmaceuticals stock forecast 2026 represents a -91.94% decrease from the last price of $70.99. For Arrowhead Pharmaceuticals stock forecast 2030, 12 predictions are offered for each month of 2030 with average Arrowhead Pharmaceuticals stock forecast of $3.46, a high forecast of $3.56, and a low forecast of $3.34. The average Arrowhead Pharmaceuticals stock forecast 2030 represents a -95.12% decrease from the last price of $70.99. For Arrowhead Pharmaceuticals stock forecast 2031 (10 year), 4 predictions are offered for each month of 2031 with average Arrowhead Pharmaceuticals stock forecast of $3.3, a high forecast of $3.31, and a low forecast of $3.29. The average Arrowhead Pharmaceuticals stock forecast 2031 represents a -95.35% decrease from the last price of $70.99. Please, see more forecasts below.